Works matching IS 10837159 AND DT 2024 AND VI 29 AND IP 3
Results: 25
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 254, doi. 10.1093/oncolo/oyad348
- By:
- Publication type:
- Article
Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 263, doi. 10.1093/oncolo/oyad346
- By:
- Publication type:
- Article
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 272, doi. 10.1093/oncolo/oyad345
- By:
- Publication type:
- Article
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 185, doi. 10.1093/oncolo/oyad344
- By:
- Publication type:
- Article
Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 219, doi. 10.1093/oncolo/oyad341
- By:
- Publication type:
- Article
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e414, doi. 10.1093/oncolo/oyad336
- By:
- Publication type:
- Article
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 270, doi. 10.1093/oncolo/oyad331
- By:
- Publication type:
- Article
Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e319, doi. 10.1093/oncolo/oyad301
- By:
- Publication type:
- Article
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 213, doi. 10.1093/oncolo/oyad317
- By:
- Publication type:
- Article
Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 227, doi. 10.1093/oncolo/oyad312
- By:
- Publication type:
- Article
Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e382, doi. 10.1093/oncolo/oyad279
- By:
- Publication type:
- Article
Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-Up.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 192, doi. 10.1093/oncolo/oyad311
- By:
- Publication type:
- Article
Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e360, doi. 10.1093/oncolo/oyad324
- By:
- Publication type:
- Article
Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e337, doi. 10.1093/oncolo/oyad299
- By:
- Publication type:
- Article
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e330, doi. 10.1093/oncolo/oyad296
- By:
- Publication type:
- Article
Construction of a Diagnostic Model for Small Cell Lung Cancer Combining Metabolomics and Integrated Machine Learning.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e392, doi. 10.1093/oncolo/oyad261
- By:
- Publication type:
- Article
Perspectives on the Treatment of Multiple Myeloma.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 200, doi. 10.1093/oncolo/oyad306
- By:
- Publication type:
- Article
HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e309, doi. 10.1093/oncolo/oyad275
- By:
- Publication type:
- Article
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e372, doi. 10.1093/oncolo/oyad273
- By:
- Publication type:
- Article
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 244, doi. 10.1093/oncolo/oyad267
- By:
- Publication type:
- Article
Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e345, doi. 10.1093/oncolo/oyad291
- By:
- Publication type:
- Article
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 235, doi. 10.1093/oncolo/oyad254
- By:
- Publication type:
- Article
Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e299, doi. 10.1093/oncolo/oyad199
- By:
- Publication type:
- Article
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e351, doi. 10.1093/oncolo/oyad194
- By:
- Publication type:
- Article
Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 190, doi. 10.1093/oncolo/oyad145
- By:
- Publication type:
- Article